• 

  CTAD: Leqembi’s Origin Story, 30 Years Ago in Arctic Sweden
• 

  UK Health Services Says Leqembi Is Too Costly, Too Risky to Cover
• 

  What Happens When Insurance Refuses to Cover Your Alzheimer’s Prescription?
• 

  EU Regulators Reject Alzheimer’s Drug Leqembi
• 

  Alzheimer’s Rates Are Highest In These Counties—But No Leqembi Access
• 

  Leading Neurologist: This Gene Raises Your Risk of Alzheimer’s—and Drug Side Effects
• 

  Alzheimer’s Drugs and ARIA: Leqembi ‘Brain Bleeds’ Side Effect, Explained
• 

  FAQ: What Is Alzheimer’s Drug Leqembi, Where Is It Approved, and More
• 

  OP-ED: New Alzheimer’s Drugs Don’t Deserve the Hype
• 

  With Full FDA Approval, Alzheimer’s Drug Leqembi Now Covered By Medicare
• 

  Is Leqembi Safe? What to Know About the New Alzheimer’s Drug’s Side Effects
• 

  Phil’s Journal: Will New Alzheimer’s Drugs Work for As Well for Women as They Do for Men?
• 

  On the Verge of Full FDA Approval, New Details About Leqembi Death
• 

  Leqembi Clinical Trials Aren’t Over—Half of Participants Will Get the Drug for Free
• 

  A Trial Participant’s Inside Look at New Alzheimer’s Drug Leqembi

Previous123Next